Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0286-2025Class II

epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System, SMN 10736515

Siemens Healthcare Diagnostics Inc. / initiated 2024-09-24 / Open, Classified

Siemens Healthcare Diagnostics Inc began a recall of epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System, SMN 10736515 on . FDA classified it as Class II and gives the reason as "Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in one lot of epoc BGEM BUN Test Cards approximately 2 months prior to expiration. The observed maximum negative bias from internal...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0286-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System, SMN 10736515
Product code
CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph
Reason for recall
Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in one lot of epoc BGEM BUN Test Cards approximately 2 months prior to expiration. The observed maximum negative bias from internal testing is -10 mmol/L. No positive bias has been observed. Quality Control (QC) fluid may or may not detect the issue depending on the bias magnitude and the frequency of QC testing. One customer complaint has been associated with this issue. No adverse events have been reported. All affected lots have recently expired before the issuance of the recall.
FDA root cause
Under Investigation by firm
Action
An Urgent Medical Device Correction letter dated September 2024 was sent to customers. Customer Actions " Please review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable. " If you are a distributor, please ensure your customers receive this UMDC letter. " Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. " Adverse reactions or quality problems experienced with the use of the affected products listed in the above table may be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail or by fax. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. " For any questions, you may call Siemens Healthineers Technical Solutions Center at 877-229-3711.
Quantity in commerce
1292 units
Distribution
US Nationwide. Canada.
Product codes and lots
UDI-DI: 00809708121860; Lot Numbers: 08-24092-60 08-24093-60 08-24094-60 08-24095-60 08-24096-60

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0286-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0286-2025Class IIOngoingVoluntary: Firm initiated